| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 11/18/1999 | WO1999058571A2 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 11/18/1999 | WO1999058570A2 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 11/18/1999 | WO1999058568A1 Gprw receptor |
| 11/18/1999 | WO1999058563A2 Moraxella catharralis proteins |
| 11/18/1999 | WO1999058561A1 Hepatitis c virus mimotopes |
| 11/18/1999 | WO1999058559A2 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 11/18/1999 | WO1999058558A2 Cell signaling proteins |
| 11/18/1999 | WO1999058546A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene |
| 11/18/1999 | WO1999058157A1 Method for inhibiting antibody-mediated rejection of xenogeneic tissues |
| 11/18/1999 | WO1999058153A1 Methods of diagnosing and modulating autoimmunity |
| 11/18/1999 | WO1999058150A1 Preventives/remedies for hepatic cirrhosis |
| 11/18/1999 | WO1999058147A1 APOPTOSIS OF NAIVE HUMAN NK CELLS BY CROSSLINKING OF THEIR FcγRIIIa MOLECULES WIHT A RAT IgG2b (LO-CD2a/BTI-322) OR ITS IgG1 HUMANIZED MONOCLONAL ANTIBODY |
| 11/18/1999 | WO1999058139A2 Methods for detecting and inhibiting angiogenesis |
| 11/18/1999 | WO1999058133A2 Anti-diarrheal and method for using the same |
| 11/18/1999 | WO1999051253A3 Immune response modulation |
| 11/18/1999 | WO1999050285A3 Production methods and uses of a retrovirus |
| 11/18/1999 | WO1999049855A3 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils |
| 11/18/1999 | WO1999047683A9 Gene encoding labyrinthin, a marker for cancer |
| 11/18/1999 | WO1999047673A3 Isolated mammalian membrane protein genes and related reagents |
| 11/18/1999 | WO1999046364A9 Vascular endothelial growth factor 2 |
| 11/18/1999 | WO1999046281A9 Novel polypeptides and nucleic acids encoding the same |
| 11/18/1999 | WO1999046278A9 Viral vector directed to predetermined target cells |
| 11/18/1999 | WO1999045962A9 Transgenic non-human animals capable of producing heterologous antibodies |
| 11/18/1999 | WO1999043830A3 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity |
| 11/18/1999 | WO1999042584A9 Apoptosis inducing molecule ii and methods of use |
| 11/18/1999 | WO1999038981A3 Human protein kinase molecules |
| 11/18/1999 | WO1999037803A9 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53 |
| 11/18/1999 | WO1999037682A3 Antibodies against human il-12 |
| 11/18/1999 | WO1999036550A3 Human protease molecules |
| 11/18/1999 | WO1999036094A3 Composition and method for treating metastatic tumors or cancer induced by cells expressing sv40 tumor antigen |
| 11/18/1999 | WO1999028475A3 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 11/18/1999 | WO1999028349A3 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS |
| 11/18/1999 | WO1999027098A3 A-33 related antigens and their pharmacological uses |
| 11/18/1999 | CA2404693A1 97 human secreted proteins |
| 11/18/1999 | CA2332109A1 97 human secreted proteins |
| 11/18/1999 | CA2331314A1 Anti-diarrheal and method for using the same |
| 11/18/1999 | CA2330000A1 Diagnosis and treatment of hepatic disorders |
| 11/18/1999 | CA2328606A1 Antibodies to cd23, derivatives thereof, and their therapeutic uses |
| 11/18/1999 | CA2328601A1 Preventives/remedies for hepatic cirrhosis |
| 11/18/1999 | CA2328502A1 Cloning of basb020 antigen from moraxella catarrhalis |
| 11/18/1999 | CA2328414A1 Methods for detecting and inhibiting angiogenesis |
| 11/18/1999 | CA2328405A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene |
| 11/18/1999 | CA2328403A1 Basb029 polynucleotide(s) and polypeptides from neisseria meningitidis |
| 11/18/1999 | CA2328130A1 Moraxella catarrhalis proteins |
| 11/18/1999 | CA2327548A1 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 11/18/1999 | CA2327546A1 Transgenic plant cells expressing a recombinant plant e2f peptide |
| 11/18/1999 | CA2327354A1 Human apoptosis associated proteins |
| 11/18/1999 | CA2327351A1 Cell signaling proteins |
| 11/17/1999 | EP0957364A2 Dye-labeled protein conjugate and method for preparing the same |
| 11/17/1999 | EP0957363A2 Dye-labeled and polymerized antibody and method for preparing the same |
| 11/17/1999 | EP0957362A2 Dye-labeled protein conjugate and method for preparing the same |
| 11/17/1999 | EP0957361A2 Dye-labeled and polymerized antibody and method for preparing the same |
| 11/17/1999 | EP0957166A1 HUMANIZED IMMUNOGLOBULIN REACTING SPECIFICALLY WITH Fas LIGAND OR ACTIVE FRAGMENTS THEREOF AND REGION INDUCING APOPTOSIS ORIGINATING IN Fas LIGAND |
| 11/17/1999 | EP0957162A1 Biological viral material obtained from a multiple sclerosis-associated virus strain infected cell line |
| 11/17/1999 | EP0957111A2 Specific binding proteins for treating canine allergy |
| 11/17/1999 | EP0956862A1 Methods of increasing lean tissue mass using ob protein compositions |
| 11/17/1999 | EP0956508A1 Icam-4 and diagnostic uses thereof |
| 11/17/1999 | EP0956506A1 Treatment and diagnosis of cancer |
| 11/17/1999 | EP0956504A2 Antibody to and assay for peptide linked-pyridinoline as indicator of bone resorption level |
| 11/17/1999 | EP0956360A1 Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses |
| 11/17/1999 | EP0956353A1 MANIPULATION OF CELLULOSE AND/OR $g(b)-1,4-GLUCAN |
| 11/17/1999 | EP0956351A1 A tumor necrosis factor related ligand |
| 11/17/1999 | EP0956350A1 Human chloride channel protein (hccp) |
| 11/17/1999 | EP0956339A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 11/17/1999 | EP0956304A1 Dendritic cell-specific antibodies |
| 11/17/1999 | EP0956302A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes |
| 11/17/1999 | EP0956298A1 Snrnp sm proteins |
| 11/17/1999 | EP0956291A1 Dna encoding galanin galr3 receptors and uses thereof |
| 11/17/1999 | EP0956290A1 Gp120 polypeptides having conformational discontinuous chemokine receptor binding sites and methods of inhibiting hiv infection |
| 11/17/1999 | EP0956289A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 11/17/1999 | EP0956053A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33 |
| 11/17/1999 | EP0956049A2 Conjugates of thrombin inhibitors and endogenes carriers |
| 11/17/1999 | EP0956046A2 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 11/17/1999 | EP0956044A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
| 11/17/1999 | EP0956032A1 Proteins and compositions for modulating mitosis |
| 11/17/1999 | EP0956030A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 11/17/1999 | EP0955948A1 Induction of immunological tolerance |
| 11/17/1999 | EP0955803A1 Plant retroviral polynucleotides and methods for use thereof |
| 11/17/1999 | EP0805871B1 Anti-cd30 antibodies preventing proteolytic cleavage and release of membrane-bound cd30 antigen |
| 11/17/1999 | CN1235639A Reconstituted human anti-HM1.24 antibody |
| 11/17/1999 | CN1235556A Materials and methods relating to diagnosis and treatment of pre-eclampsia and diabetes |
| 11/17/1999 | CN1235555A Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 11/16/1999 | US5986170 Murine model for human carcinoma |
| 11/16/1999 | US5986069 Human haemopoietic maturation factor polypeptides |
| 11/16/1999 | US5986065 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 11/16/1999 | US5986064 Antibodies which specifically bind to human tumor-associated Kazal inhibitor-like polypeptide |
| 11/16/1999 | US5986061 Phosphorylated fusion proteins |
| 11/16/1999 | US5986054 Genetic sequences and proteins related to alzheimer's disease |
| 11/16/1999 | US5986051 Genes of Helicobacter pylori necessary for the regulation and maturation of urease and their use |
| 11/16/1999 | US5985822 Relates to peptides comprising at least part of the amino acid sequence of neural cell adhesion molecule (n-cam) and to compositions that utilize these peptides to inhibit dna synthesis and cell division of glial cells |
| 11/16/1999 | US5985656 Human cell line comprising, double negative suppressor cells characterized by specific surface marker pattern, which inhibit the mixed lymphocyte reaction in vitro, but do not kill corresponding target cells; density gradient separation |
| 11/16/1999 | US5985646 Thermostable isolated polynucleotide encoding an enzyme wtih amidase activity; an enzyme having activity in the removal of arginine, phenylalanine or methionine from the n-terminal end of peptides in peptide or peptidomimetic synthesis |
| 11/16/1999 | US5985640 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 11/16/1999 | US5985626 Schiff base |
| 11/16/1999 | US5985619 Amplification of target nucleic acid |
| 11/16/1999 | US5985615 Directed switch-mediated DNA recombination |
| 11/16/1999 | US5985613 Use of an "immunodeficiency-virus suppressing lymphokine (ISL) "to inhibit the replication of viruses, in particular of retroviruses |
| 11/16/1999 | US5985606 Human preprotachykinin B |
| 11/16/1999 | US5985604 Polynucleotide |
| 11/16/1999 | US5985603 P2x receptor DNA and protein sequence |